Among active 13F managers last quarter, 4 opened and 1 added, while none reduced or exited; the largest holder to move was Citadel Advisors LLC (new position). Over the last 180 days, 1 insider bought and none sold, a net +$106K in open-market trades.
Funds lean in and no leg opposes.
17 tracked 13F filers disclose a position in ADIL as of the latest SEC 13F filings, a combined $203K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Citadel Advisors LLC | 30K | $76K | ▲New +30K sh | Q2 2026 | |
| 2 | StoneX Group Inc. | 20K | $36K | ▲New +20K sh | Q2 2026 | |
| 3 | Geode Capital Management, LLC | 12K | $32K | ▼−49% Reduced · −12K sh | Q2 2026 | |
| 4 | China Universal Asset Management Co., Ltd. | 8K | $20K | ▲New +8K sh | Q2 2026 | |
| 5 | Vanguard Fiduciary Trust Co | 6K | $15K | —Held | Q2 2026 | |
| 6 | Vanguard Capital Management LLC | 6K | $15K | ▲16× Added · +5K sh | Q2 2026 | |
| 7 | Manchester Capital Management LLC | 2K | $5K | —Held | Q2 2026 | |
| 8 | Tower Research Capital LLC (TRC) | 1K | $2K | ▲+1.1% Added · +15 sh | Q1 2026 | |
| 9 | UBS Group AG | 542 | $970 | ▼−94% Reduced · −9K sh | Q1 2026 | |
| 10 | BlackRock, Inc. | 304 | $778 | ▼−73% Reduced · −806 sh | Q2 2026 | |
| 11 | Raffa Wealth Management, LLC | 83 | $212 | —Held | Q2 2026 | |
| 12 | Morgan Stanley | 50 | $90 | ▲+456% Added · +41 sh | Q1 2026 | |
| 13 | SBI Securities Co., Ltd. | 47 | $120 | —Held | Q2 2026 | |
| 14 | Wells Fargo & Company | 6 | $11 | ▼−96% Reduced · −154 sh | Q1 2026 | |
| 15 | Northwestern Mutual Wealth Management Co | 4 | $7 | ▲New +4 sh | Q1 2026 | |
| 16 | Harbour Investments, Inc. | 3 | $5 | ▲New +3 sh | Q1 2026 | |
| 17 | Abound Wealth Management | 1 | $3 | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 4 funds opened a new position in ADIL and 1 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 7 funds | $3.1B |
| Amazon.com IncAMZN | 7 funds | $2.9B |
| Apple IncAAPL | 7 funds | $2.7B |
| Microsoft CorpMSFT | 7 funds | $1.7B |
| Alphabet Inc-CL AGOOGL | 7 funds | $1.3B |
| Broadcom IncAVGO | 7 funds | $1.2B |
| Eli Lilly & CoLLY | 7 funds | $1.2B |
| Alphabet Inc-CL CGOOG | 7 funds | $1.1B |
| Advanced Micro DevicesAMD | 7 funds | $1.0B |
| Micron Technology IncMU | 7 funds | $998.8M |
| Abbvie IncABBV | 7 funds | $883.9M |
| Applied Materials IncAMAT | 7 funds | $846.9M |
Ranked by how many of ADIL's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ADIL.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 16, 2026 | Coastlands Capital LP | 10% Owner | Buy (P) | 1K | $3K |
| Jul 14, 2026 | Coastlands Capital LP | 10% Owner | Buy (P) | 2K | $5K |
| Jul 10, 2026 | Coastlands Capital LP | 10% Owner | Buy (P) | 2K | $5K |
| Jul 9, 2026 | Coastlands Capital LP | 10% Owner | Buy (P) | 10K | $28K |
| Jun 29, 2026 | Coastlands Capital LP | 10% Owner | Buy (P) | 25K | $65K |
| Sep 29, 2023 | Schuyler Kevin | Director | Buy (P) | 700 | $2K |
| Dec 30, 2021 | Newman James W. Jr. | Director | Buy (P) 3 lots, same day | 25K | $67K |
| Nov 30, 2021 | Stilley William B. III | Chief Executive Officer, Director, 10% Owner | Buy (P) | 11K | $29K |
| Nov 29, 2021 | Stilley William B. III | Chief Executive Officer, Director, 10% Owner | Buy (P) | 10K | $26K |
| Nov 26, 2021 | Newman James W. Jr. | Director | Buy (P) | 10K | $29K |
| Oct 4, 2021 | Johnson Bankole A. | Chief Medical Officer | Sell (S) | 200K | — |
| Apr 6, 2021 | Johnson Bankole A. | Chief Medical Officer | Sell (S) | 150K | $375K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 3 | 4 | – |
Insiders Form 4 open-market | 1 | 0 | +$106K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for ADIL
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ADIL/capital-change-brief"
Use Arkolith's capital_change_brief for ADIL. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ADIL. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.